Sera Prognostics (SERA) Operating Margin Growth (3y) (2023 - 2026)

Sera Prognostics (SERA) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.91 Bn 176.62 Bn 6.27 Bn -343.00
2 Stryker 128.87 Bn 125.99 Bn 3.81 Bn 17.00
3 Medtronic 108.72 Bn 99.50 Bn 6.41 Bn 78.00
4 Boston Scientific 68.46 Bn 67.01 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 48.53 Bn 44.85 Bn 1.29 Bn -283.00
6 Dexcom 28.37 Bn 27.25 Bn 750.30 Mn 1,505.00
7 GE HealthCare Technologies 28.34 Bn 26.06 Bn 1.98 Bn -184.00
8 Smith & Nephew 26.91 Bn 26.33 Bn - -
9 Koninklijke Philips 25.47 Bn 22.34 Bn 2.07 Bn 2,016.00
10 Sera Prognostics 107.05 Mn 107.05 Mn -28,000.00 -5.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.55 Mn
Dec 31, 2025 -7.35 Mn
Sep 30, 2025 -4.33 Mn
Jun 30, 2025 -3.98 Mn
Mar 31, 2025 802,632.00
Dec 31, 2024 899,519.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 -164,917.00
Dec 31, 2023 5.77 Mn
Sep 30, 2023 7.34 Mn
Jun 30, 2023 6.20 Mn